Ausdal Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$334K Sell
7,206
-1,841
-20% -$85.2K 0.02% 523
2025
Q1
$552K Buy
9,047
+1,713
+23% +$104K 0.04% 372
2024
Q4
$415K Buy
7,334
+373
+5% +$21.1K 0.04% 396
2024
Q3
$360K Sell
6,961
-1,218
-15% -$63K 0.04% 369
2024
Q2
$340K Sell
8,179
-639
-7% -$26.5K 0.04% 362
2024
Q1
$478K Buy
8,818
+308
+4% +$16.7K 0.06% 280
2023
Q4
$437K Sell
8,510
-263
-3% -$13.5K 0.05% 277
2023
Q3
$509K Sell
8,773
-843
-9% -$48.9K 0.07% 246
2023
Q2
$615K Sell
9,616
-686
-7% -$43.9K 0.08% 211
2023
Q1
$714K Buy
10,302
+1,623
+19% +$112K 0.1% 199
2022
Q4
$624K Buy
8,679
+288
+3% +$20.7K 0.09% 208
2022
Q3
$596K Buy
8,391
+738
+10% +$52.4K 0.09% 218
2022
Q2
$589K Sell
7,653
-232
-3% -$17.9K 0.09% 235
2022
Q1
$576K Buy
7,885
+1,812
+30% +$132K 0.08% 252
2021
Q4
$379K Buy
6,073
+357
+6% +$22.3K 0.05% 334
2021
Q3
$338K Buy
5,716
+28
+0.5% +$1.66K 0.05% 337
2021
Q2
$380K Sell
5,688
-44
-0.8% -$2.94K 0.06% 308
2021
Q1
$362K Buy
5,732
+82
+1% +$5.18K 0.06% 307
2020
Q4
$350K Sell
5,650
-96
-2% -$5.95K 0.07% 281
2020
Q3
$346K Buy
5,746
+1,304
+29% +$78.5K 0.08% 234
2020
Q2
$261K Sell
4,442
-1,470
-25% -$86.4K 0.09% 228
2020
Q1
$365K Sell
5,912
-151
-2% -$9.32K 0.13% 171
2019
Q4
$389K Buy
+6,063
New +$389K 0.12% 213
2018
Q4
Sell
-5,466
Closed -$339K 259
2018
Q3
$339K Buy
5,466
+268
+5% +$16.6K 0.1% 254
2018
Q2
$288K Buy
5,198
+1,210
+30% +$67K 0.09% 287
2018
Q1
$252K Sell
3,988
-924
-19% -$58.4K 0.09% 284
2017
Q4
$301K Sell
4,912
-2,599
-35% -$159K 0.11% 248
2017
Q3
$479K Buy
7,511
+564
+8% +$36K 0.19% 153
2017
Q2
$387K Buy
6,947
+313
+5% +$17.4K 0.17% 173
2017
Q1
$361K Sell
6,634
-3,261
-33% -$177K 0.16% 166
2016
Q4
$578K Sell
9,895
-1,326
-12% -$77.5K 0.27% 99
2016
Q3
$605K Buy
11,221
+4,276
+62% +$231K 0.3% 95
2016
Q2
$511K Buy
6,945
+136
+2% +$10K 0.26% 98
2016
Q1
$435K Buy
6,809
+375
+6% +$24K 0.25% 111
2015
Q4
$443K Buy
+6,434
New +$443K 0.22% 107